Total Payments
$15,882
2024 Payments
$6,892
Companies
38
Transactions
190
Medicare Patients
1,876
Medicare Billing
$176,594
Payment Breakdown by Category
Food & Beverage$10,227 (64.4%)
Consulting$4,560 (28.7%)
Travel$1,089 (6.9%)
Education$6.02 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,227 | 184 | 64.4% |
| Consulting Fee | $4,560 | 1 | 28.7% |
| Travel and Lodging | $1,089 | 4 | 6.9% |
| Education | $6.02 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $6,517 | 20 | $0 (2024) |
| Novo Nordisk Inc | $1,173 | 26 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $818.24 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $797.44 | 22 | $0 (2020) |
| Allergan Inc. | $749.54 | 14 | $0 (2019) |
| PFIZER INC. | $474.52 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $462.04 | 18 | $0 (2023) |
| Janssen Products, LP | $369.76 | 3 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $364.68 | 4 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $363.04 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,892 | 31 | Gilead Sciences, Inc. ($6,289) |
| 2023 | $861.09 | 13 | E.R. Squibb & Sons, L.L.C. ($263.43) |
| 2022 | $384.05 | 8 | AstraZeneca Pharmaceuticals LP ($196.75) |
| 2021 | $343.25 | 9 | Paratek Pharmaceuticals, Inc. ($110.79) |
| 2020 | $1,336 | 27 | Novo Nordisk Inc ($476.19) |
| 2019 | $2,662 | 45 | Novo Nordisk Inc ($423.60) |
| 2018 | $1,743 | 31 | Janssen Pharmaceuticals, Inc ($261.83) |
| 2017 | $1,662 | 26 | Regeneron Healthcare Solutions, Inc. ($234.88) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $118.74 | General |
| Category: COVID-19 | ||||||
| 09/18/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $4,560.00 | General |
| Category: COVID-19 | ||||||
| 09/18/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $24.00 | General |
| Category: COVID-19 | ||||||
| 09/18/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: COVID-19 | ||||||
| 09/18/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: COVID-19 | ||||||
| 09/18/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: COVID-19 | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $53.33 | General |
| Category: COVID-19 | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $44.44 | General |
| Category: COVID-19 | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $38.55 | General |
| Category: COVID-19 | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.74 | General |
| 09/12/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: COVID-19 | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $582.94 | General |
| Category: COVID-19 | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $261.06 | General |
| Category: COVID-19 | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $220.54 | General |
| Category: COVID-19 | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $108.70 | General |
| Category: COVID-19 | ||||||
| 08/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.91 | General |
| 08/08/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Food and Beverage | In-kind items and services | $95.95 | General |
| Category: ANTIBIOTICS | ||||||
| 07/24/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/22/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $118.90 | General |
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $92.53 | General |
| 06/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.80 | General |
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $26.12 | General |
| 04/18/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $123.86 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 300 | 519 | $165,280 | $45,360 |
| 2022 | 5 | 343 | 423 | $77,908 | $18,346 |
| 2021 | 6 | 325 | 341 | $80,400 | $25,652 |
| 2020 | 14 | 908 | 1,137 | $237,165 | $87,236 |
Total Patients
1,876
Total Services
2,420
Medicare Billing
$176,594
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 132 | 325 | $104,080 | $30,378 | 29.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 108 | 111 | $44,400 | $9,838 | 22.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 46 | 68 | $15,300 | $4,251 | 27.8% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 14 | 15 | $1,500 | $893.10 | 59.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 168 | 223 | $50,175 | $11,332 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 68 | 74 | $11,322 | $3,296 | 29.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 40 | $12,120 | $2,448 | 20.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 56 | 71 | $2,911 | $685.20 | 23.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 15 | $1,380 | $585.15 | 42.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 165 | 178 | $48,644 | $14,872 | 30.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 84 | $14,636 | $4,929 | 33.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 28 | 28 | $10,899 | $3,444 | 31.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 11 | 11 | $3,630 | $1,507 | 41.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 17 | $1,648 | $677.17 | 41.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 23 | 23 | $943.00 | $223.33 | 23.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 227 | 358 | $75,180 | $27,451 | 36.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 172 | 172 | $56,760 | $20,609 | 36.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 173 | 231 | $32,802 | $12,612 | 38.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 59 | 76 | $21,432 | $8,679 | 40.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 71 | 71 | $23,075 | $8,630 | 37.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 29 | 29 | $11,716 | $4,032 | 34.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 19 | 19 | $4,028 | $1,356 | 33.7% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 16 | 16 | $1,488 | $939.14 | 63.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 11 | 14 | $2,954 | $827.96 | 28.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 20 | 23 | $1,978 | $751.44 | 38.0% |
About Dr. Hossein Akhondi Asl, M.D
Dr. Hossein Akhondi Asl, M.D is a Internal Medicine healthcare provider based in Henderson, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609862051.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hossein Akhondi Asl, M.D has received a total of $15,882 in payments from pharmaceutical and medical device companies, with $6,892 received in 2024. These payments were reported across 190 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($10,227).
As a Medicare-enrolled provider, Akhondi Asl has provided services to 1,876 Medicare beneficiaries, totaling 2,420 services with total Medicare billing of $176,594. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Henderson, NV
- Active Since 09/21/2005
- Last Updated 01/11/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1609862051
Products in Payments
- Veklury (Drug) $6,202
- ELIQUIS (Drug) $702.01
- AVYCAZ (Drug) $440.51
- XARELTO (Drug) $436.29
- Ozempic (Drug) $426.94
- JARDIANCE (Drug) $364.68
- INVOKANA (Drug) $355.13
- DIFICID (Drug) $348.72
- RYBELSUS (Drug) $322.69
- FARXIGA (Drug) $306.75
- Fetroja (Drug) $291.92
- Symtuza (Drug) $249.27
- NUZYRA (Drug) $248.73
- LATUDA (Drug) $237.99
- DALVANCE (Drug) $235.87
- PRALUENT ALIROCUMAB INJECTION (Biological) $234.88
- Kimyrsa (Drug) $219.81
- Yupelri (Drug) $177.57
- iFuse Implant (Device) $169.01
- Rybelsus (Drug) $155.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Henderson
Ryan Hampton, D.o, D.O
Internal Medicine — Payments: $213,538
Internal Medicine $213,538
Jeffrey Levisman, M.d, M.D
Internal Medicine — Payments: $198,615
Internal Medicine $198,615
Marigene Salazar Sharma, Md, MD
Internal Medicine — Payments: $104,164
Internal Medicine $104,164
Dr. Karthiek Narala, M.d, M.D
Internal Medicine — Payments: $41,673
Internal Medicine $41,673
Sonu Bhatia, M.d, M.D
Internal Medicine — Payments: $21,843
Internal Medicine $21,843
Dr. Justin Terry, Md, MD
Internal Medicine — Payments: $21,280
Internal Medicine $21,280